Gremlin, which is known to act as an antagonist of BMP, may also function as a non-canonical VEGFR2 agonist [18] as it can induce the formation of the VEGFR2/αVß3 integrin complex that mediates paracrine/autocrine function in tumour vascularisation [19]. This evidence concerns the gene GREM1 and neoplasm.